An2 Therapeutics, INC. 8-K Filing

Ticker: ANTX · Form: 8-K · Filed: Apr 9, 2026 · CIK: 0001880438

Sentiment: neutral

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 9, 2026 regarding AN2 Therapeutics, Inc. (ANTX).